购物车
- 全部删除
- 您的购物车当前为空
PF-562271 besylate (PF-00562271 Besylate) 是一种可逆的,有效的,ATP 竞争性的 FAK(IC50:1.5 nM)和 Pyk2 (IC50:13 nM)激酶抑制剂。
为众多的药物研发团队赋能,
让新药发现更简单!
PF-562271 besylate (PF-00562271 Besylate) 是一种可逆的,有效的,ATP 竞争性的 FAK(IC50:1.5 nM)和 Pyk2 (IC50:13 nM)激酶抑制剂。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 257 | 现货 | |
5 mg | ¥ 597 | 现货 | |
10 mg | ¥ 1,030 | 现货 | |
25 mg | ¥ 1,770 | 现货 | |
50 mg | ¥ 2,590 | 现货 | |
100 mg | ¥ 3,700 | 现货 | |
200 mg | ¥ 4,970 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 828 | 现货 |
产品描述 | PF-562271 besylate (PF-00562271 Besylate) is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs. |
靶点活性 | FAK:1.5 nM |
体外活性 | PF-562271对FAK和Pyk2酪氨酸激酶活性表现出选择性抑制效果,其IC50分别为1.5 nM和14 nM。在基于细胞的实验中,PF-562271对FAK的IC50表现为5 nM,与其他激酶靶标相比表现出更高的选择性。[1] 在二维(2D)培养条件下,PF-562271能够依剂量依赖性抑制FAK WT、FAK/和FAK激酶缺陷(KD)细胞的增殖,其IC50分别为3.3 μM、2.08 μM和2.01 μM。[2] |
体内活性 | 在多个人类皮下移植模型中,PF-562271显示出剂量依赖性的肿瘤生长抑制作用,对PC-3M、BT474、BxPc3和LoVo的最大肿瘤抑制率在每日两次,每次25至50 mg/kg剂量下,范围从78%至94%,且无体重下降、病态或死亡现象。[1] PF-562271(通过p.o.给药,25 mg/kg)在皮下和骨转移的PC3M-luc-C6移植模型中显著减缓了肿瘤进展。[3] 在Huh7.5肝细胞癌移植模型中,sunitinib和PF-562271的联合治疗针对血管生成和肿瘤侵袭性,比单一化合物治疗产生更显著的抗肿瘤效果,通过阻断肿瘤生长及影响肿瘤在撤销治疗后的恢复能力。[4] |
激酶实验 | Recombinant kinase assay and enzyme kinetics : Briefly, purified-activated FAK kinase domain (amino acid 410–689) is reacted with 50 μM ATP and 10 μg per well of a random peptide polymer of Glu and Tyr, p(Glu/Tyr), in kinase buffer [50 mM HEPES (pH 7.5), 125 mM NaCl, and 48 mM MgCl2] for 15 minutes. Phosphorylation of p(Glu/Tyr) is challenged with serially diluted PF-562271 at 1/2-Log concentrations starting at a top concentration of 1 μM. Each concentration is tested in triplicate. Phosphorylation of p(Glu/Tyr) is detected with a general antiphospho-tyrosine (PY20) antibody followed by horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG antibody. HRP substrate is added, and absorbance readings at 450 nm are obtained after addition of stop solution (2 M H2SO4). IC50 values are determined using the Hill-Slope Model. Broad kinase selectivity profiling is performed in house and by using the KinaseProfiler Selectivity Screening Service available through UpState Biotechnology. |
细胞实验 | Cells are plated for 48 hours before addition of PF-562271. After 3 days cells are fixed by addition of ice cold 25% trichloroacetic acid (TCA) solution prior to staining with Sulforhodamine B (SRB) dye solution. Plates are washed with 1% glacial acetic acid, air-dried and resuspended in 10 mM Tris buffer, pH 10.5 before reading absorbance at 540 nm. Curve fitting and generation of IC50 values is carried out using GraphPad Prism 4 software from six replicates.(Only for Reference) |
别名 | PF-00562271 Besylate |
分子量 | 665.66 |
分子式 | C21H20F3N7O3S·C6H6O3S |
CAS No. | 939791-38-5 |
Smiles | OS(=O)(=O)c1ccccc1.CN(c1ncccc1CNc1nc(Nc2ccc3NC(=O)Cc3c2)ncc1C(F)(F)F)S(C)(=O)=O |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 55 mg/mL (82.62 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容